≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other diseases of blood and blood-forming organs

DOID EFO Endpoint Browser PheWeb

D3_OTHERBLOOD

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D75
  • Cause of death: ICD-10 — D75

2 out of 7 registries used, show all original rules.

2440

4. Check minimum number of events

None

2440

5. Include endpoints

2584

6. Filter based on genotype QC (FinnGen only)

2584

Control definitions (FinnGen only)

Control exclude
D3_BLOODOTHER

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D70-D77
Name in latin
Alii morbi sanguinis et organorum haematopoeticorum

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 17063 8307 8588
Only index persons 14250 7111 7139
Unadjusted period prevalence (%)
Whole population 0.24 0.24 0.24
Only index persons 0.27 0.26 0.27
Median age at first event (years)
Whole population 60.51 61.34 59.66
Only index persons 59.31 60.14 58.49

-FinnGen-

Key figures

All Female Male
Number of individuals 2584 1280 1304
Unadjusted period prevalence (%) 0.51 0.44 0.57
Median age at first event (years) 59.18 57.57 60.75

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2343
Matched controls
23428
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
XW000
NOMESCO Finland
Bone marrow biopsy
29.4
323.0
648
301
D75.2
ICD-10 Finland
Essential thrombocytosis
3456.6
323.0
826
*
L01XX05
ATC
hydroxycarbamide; oral
170.7
323.0
608
48
D75.1
ICD-10 Finland
Secondary polycythaemia
3092.0
323.0
706
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
34.3
323.0
750
317
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
150.9
323.0
509
43
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
2301.9
323.0
652
*
D45
ICD-10 Finland
Polycythaemia vera
67.2
268.9
310
53
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
48.4
212.0
259
60
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
237.4
192.6
196
9
D75.0
ICD-10 Finland
Familial erythrocytosis
604.3
172.6
169
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
76.1
108.5
123
17
TPH00
NOMESCO Finland
Phlebotomy
62.8
107.2
125
21
L01XX35
ATC
anagrelide; oral
228.4
106.5
109
5
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
514.1
100.3
99
*
SPAT1074
SPAT
Venesection
56.4
95.3
113
21
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
91.0
494
1663
L03AB05
ATC
interferon alfa-2b; parenteral
48.1
79.6
97
21
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
56.9
311
1024
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
123.1
56.1
60
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
54.3
1115
7327
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
43.0
54.1
67
16
28900
ICD-8 Finland
Other disease of blood and blood-forming organs, Polycythaemia, secondary
+∞
43.9
42
*
L03AB04
ATC
interferon alfa-2a; parenteral
52.1
42.8
51
10
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
47.3
42.1
51
11
M04AA01
ATC
allopurinol; systemic
2.4
42.0
394
1797
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
66.9
40.2
46
7
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
18.9
38.4
59
32
28998
ICD-8 Finland
Other disease of blood and blood-forming organs, Alii definiti
+∞
34.5
33
*
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
15.3
34.4
57
38
B99
ICPC
Blood/lymph/spleen disease other
20.0
34.0
51
26
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
32.9
692
4364
174
Kela drug reimbursment
Ruxolitinib
86.3
30.8
34
*
28999
ICD-8 Finland
Other disease of blood and blood-forming organs, Other and unspecified
+∞
28.2
27
*
R71
ICD-10 Finland
Abnormality of red blood cells
33.2
27.8
36
11
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
7.9
27.3
63
82
C03CA01
ATC
furosemide; systemic
1.7
27.0
670
4398
374
Kela drug reimbursment
Ruxolitinib
97.9
26.7
29
*
Z2221
NOMESCO Finland
Medical doctor
1.7
25.8
638
4175
B01AB05
ATC
enoxaparin; parenteral
1.7
25.3
696
4693
ZXE00
NOMESCO Finland
One hour or less
1.6
25.2
882
6349
C07AB07
ATC
bisoprolol; oral
1.6
24.5
1073
8160
WW500
NOMESCO Finland
Blood transfusion
3.4
24.5
121
365
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
22.3
23.0
33
15
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
116.1
21.6
23
*
L01EJ01
ATC
ruxolitinib; oral
116.1
21.6
23
*
H02AB06
ATC
prednisolone; systemic
1.5
21.5
1019
7815
L01XE18
ATC
[U] ruxolitinib; oral
60.6
20.9
24
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
37.5
20.8
26
7
A02BC02
ATC
pantoprazole; systemic
1.5
20.8
1424
11830
D70.89
ICD-10 Finland
Neutropenic splenomegaly
42.0
20.5
25
6
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
32.8
20.2
26
8
212
Kela drug reimbursment
Gout
4.3
20.2
76
182
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.4
19.8
170
730
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
19.8
405
2475
R50.9
ICD-10 Finland
Fever, unspecified
1.9
19.4
302
1681
Z3231
NOMESCO Finland
Registered nurse
1.6
19.2
606
4180
T90
ICPC
Diabetes non-insulin dependent
1.7
19.2
520
3445
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.1
19.1
60
119
N02AX02
ATC
tramadol; systemic, rectal
1.5
19.0
938
7188
L03AA04
ATC
NA
34.6
18.9
24
7
C03DA01
ATC
spironolactone; oral
2.0
18.7
261
1393
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
18.4
189
886
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
18.3
1289
10626
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
17.7
18.2
28
16
B01AA03
ATC
warfarin; systemic
1.7
17.9
457
2968
Z3226
NOMESCO Finland
Physiotherapist
1.7
17.9
410
2583
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.3
17.9
168
753
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
17.8
372
2282
B01AC14
ATC
[U] anagrelide; oral
+∞
17.7
17
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
17.2
466
3077
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
17.0
508
3440
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
17.0
307
1797
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
16.9
588
4137
SPAT1262
SPAT
Handing over of treatment supplies
1.7
16.9
417
2681
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
16.6
534
3682
R06.0
ICD-10 Finland
Dyspnoea
1.6
16.3
538
3729
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
16.2
235
1271
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
16.0
780
5903
G47.3
ICD-10 Finland
Sleep apnoea
1.6
15.9
470
3168
A10BA02
ATC
metformin; oral
1.5
15.5
599
4303
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
15.3
469
3188
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
20.2
15.1
22
11
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
14.0
15.0
25
18
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
14.9
337
2106
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
14.8
442
2981
R03AC02
ATC
salbutamol; inhalant
1.4
14.8
1071
8723
ZX120
NOMESCO Finland
Intravenous
2.0
14.6
205
1095
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
14.5
216
1179
D75
ICD-10 Finland
Other diseases of blood and blood-forming organs
150.9
14.5
15
*
ZXD05
NOMESCO Finland
Urgent procedure
1.5
14.2
642
4761
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
42.7
14.1
17
*
R03BB04
ATC
tiotropium bromide; inhalant
1.9
14.1
226
1267
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.9
14.0
210
1148
J96.1
ICD-10 Finland
Chronic respiratory failure
3.5
13.9
64
185
D70.82
ICD-10 Finland
Drug-induced neutropenia
30.2
13.9
18
6
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
13.8
148
708
C90.0
ICD-10 Finland
Multiple myeloma
5.6
13.6
39
71
D73.5
ICD-10 Finland
Infarction of spleen
+∞
13.5
13
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
13.5
157
777
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
25.9
13.4
18
7
B28
ICPC
Limited function/disability (B)
9.1
13.2
27
30
J01DB01
ATC
cefalexin; oral
1.4
13.2
1774
16007
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
12.9
480
3400
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
12.9
232
1352
D58.2
ICD-10 Finland
Other haemoglobinopathies
50.3
12.8
15
*
M79.6
ICD-10 Finland
Pain in limb
1.4
12.7
714
5500
WW200
NOMESCO Finland
Immunization
3.0
12.7
73
249
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
12.7
701
5386
189
Kela drug reimbursment
Imatinib
15.5
12.6
20
13
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
12.4
581
4318
R4110
NOMESCO Finland
Physiotherapy
1.5
12.3
549
4037
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
12.3
218
1261
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
12.1
327
2142
J01MA12
ATC
levofloxacin; systemic
1.6
12.1
386
2634
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
12.1
209
1200
Z2446
NOMESCO Finland
Social worker
2.1
11.9
135
664
N06AX11
ATC
mirtazapine; oral
1.4
11.7
642
4909
E29.1
ICD-10 Finland
Testicular hypofunction
4.4
11.7
41
94
2890X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Polycythaemia, secondary[ERYTHROCYTOSIS SECUNDARIA, NUD]
+∞
11.5
11
*
2898X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Other specified diseases of blood and blood-forming organs
+∞
11.5
11
*
C09AA05
ATC
ramipril; oral
1.5
11.4
518
3816
N02BE01
ATC
paracetamol; systemic, rectal
1.4
11.4
1866
17137
C08CA01
ATC
amlodipine; oral
1.4
11.4
753
5951
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
11.2
202
1177
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
11.2
546
4075
R5140
NOMESCO Finland
Monitoring the use of the aid
1.7
11.2
222
1332
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
11.2
125
611
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
11.1
174
967
D69.1
ICD-10 Finland
Qualitative platelet defects
20.1
11.1
16
8
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.2
11.1
108
497
UJF32
NOMESCO Finland
Coloscopy
1.4
11.0
528
3930
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.4
10.9
93
401
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
10.8
212
1270
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.9
10.8
169
939
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.2
10.8
108
503
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.7
10.7
216
1304
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
10.7
660
5139
R53
ICD-10 Finland
Malaise and fatigue
1.5
10.6
392
2765
R11
ICD-10 Finland
Nausea and vomiting
1.9
10.6
158
866
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
10.4
223
1367
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
+∞
10.4
10
*
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
10.4
10
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
16.1
10.3
16
10
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
10.3
741
5916
N05BA04
ATC
oxazepam; oral
1.4
10.3
482
3566
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.2
10.2
97
442
C07AB02
ATC
metoprolol; systemic
1.5
10.1
436
3172
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
10.0
334
2297
L01XE01
ATC
[U] imatinib; oral
14.6
10.0
16
11
L04AD01
ATC
ciclosporin; systemic
3.5
9.9
44
126
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
9.8
1005
8467
N07BA03
ATC
varenicline; oral
2.1
9.7
106
514
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
9.7
925
7702
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
9.7
112
555
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
9.7
145
794
J01FF01
ATC
clindamycin; systemic
1.4
9.6
541
4132
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
9.6
102
488
A10BH01
ATC
sitagliptin; oral
1.7
9.5
192
1159
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.1
9.4
35
86
B04
ICPC
Blood symptom/complaint
6.6
9.4
23
35
122
Kela drug reimbursment
Aplastic anaemia
100.4
9.4
10
*
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
30.1
9.4
12
*
2899X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Unspecified diseases of blood and blood-forming organs
+∞
9.4
9
*
S97
ICPC
Chronic ulcer skin
2.0
9.3
120
620
TFP20
NOMESCO Finland
Cardiodefibrillation
1.8
9.3
155
880
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
9.3
319
2210
A10AE04
ATC
insulin glargine; parenteral
1.7
9.3
189
1143
WX002
NOMESCO Finland
Sedation and analgesia
1.5
9.2
398
2892
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
5.5
9.2
26
48
AA1AD
NOMESCO Finland
CT of head and brain
1.4
9.1
474
3566
Z2445
NOMESCO Finland
Psychologist
2.5
9.1
70
289
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
9.0
529
4066
H02AB09
ATC
hydrocortisone; systemic
2.8
9.0
54
193
B01AB10
ATC
tinzaparin; parenteral
1.9
9.0
135
741
ZY010
NOMESCO Finland
Hospital outpatient
2.2
8.9
86
396
205
Kela drug reimbursment
Chronic hypertension
1.4
8.9
583
4562
N05CF01
ATC
zopiclone; oral
1.4
8.9
644
5124
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
8.9
785
6443
315
Kela drug reimbursment
Clopidogrel
4.1
8.8
33
82
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.8
8.8
149
854
C08CA05
ATC
nifedipine; systemic
1.9
8.7
135
749
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
8.7
146
833
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
8.6
270
1829
WX892
NOMESCO Finland
Monitored bed care
1.8
8.6
156
913
B01AC04
ATC
clopidogrel; oral
1.5
8.6
319
2242
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
16.3
8.5
13
8
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
8.5
148
853
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
4.9
8.5
26
53
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.6
8.5
58
223
WX402
NOMESCO Finland
General anaesthesia
1.5
8.4
314
2212
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
8.3
126
692
Q21.81
ICD-10 Finland
Eisenmenger's syndrome
+∞
8.3
8
*
127
Kela drug reimbursment
Transplant complication
3.7
8.3
34
92
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
8.6
8.3
17
20
J01DA01
ATC
[U] cefalexin; systemic
1.3
8.3
1291
11423
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
8.3
137
780
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.9
8.2
116
625
XG466
NOMESCO Finland
Sleep oxymetry
2.3
8.2
72
316
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
8.2
578
4572
J01MA02
ATC
ciprofloxacin; systemic
1.3
8.2
778
6436
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
8.1
231
1530
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
8.1
347
2513
WX110
NOMESCO Finland
Local anesthesy
1.3
8.1
1381
12350
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.0
8.0
96
486
I50.0
ICD-10 Finland
Congestive heart failure
1.8
8.0
142
823
N05CF02
ATC
zolpidem; oral
1.5
8.0
334
2407
A10BK03
ATC
empagliflozin; oral
1.8
8.0
140
810
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
8.0
266
1828
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
8.0
280
1945
M10.9
ICD-10 Finland
Gout, unspecified
1.8
8.0
138
796
A46
ICD-10 Finland
Erysipelas
1.5
8.0
284
1978
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
4.4
7.9
27
62
C01AA05
ATC
digoxin; systemic
1.7
7.9
161
978
J01CA04
ATC
amoxicillin; systemic
1.3
7.8
1651
15145
A12BA01
ATC
potassium chloride; oral
2.0
7.8
92
463
R04.0
ICD-10 Finland
Epistaxis
1.7
7.8
150
894
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
7.8
212
1390
N03AX16
ATC
pregabalin; oral
1.4
7.7
456
3500
K92.1
ICD-10 Finland
Melaena
2.0
7.7
100
523
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
7.7
453
3473
D72.1
ICD-10 Finland
Eosinophilia
45.1
7.7
9
*
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
7.7
1384
12417
A04AA01
ATC
ondansetron; systemic, rectal
1.9
7.7
117
647
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
7.6
111
606
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.0
7.6
94
480
A10BJ02
ATC
liraglutide; parenteral
2.5
7.6
56
226
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.5
7.6
305
2181
N06AA09
ATC
amitriptyline; systemic
1.6
7.5
193
1244
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.3
7.5
63
274
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.8
7.5
45
163
B86
ICPC
OTHER HAEMATOLOGICAL ABNORMALITY
80.3
7.4
8
*
B03XA02
ATC
darbepoetin alfa; parenteral
2.9
7.4
43
151
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.9
7.3
100
532
D73.0
ICD-10 Finland
Hyposplenism
+∞
7.3
7
*
A10BJ06
ATC
semaglutide; parenteral
2.3
7.3
66
296
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.0
7.1
89
460
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
7.1
224
1521
WX723
NOMESCO Finland
CPAP therapy
2.2
7.1
72
340
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.9
7.1
41
144
Y28
ICPC
Limited function/disability (Y)
5.3
7.1
20
38
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
7.0
140
845
C02AC05
ATC
moxonidine; oral
1.9
7.0
94
497
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.9
7.0
92
483
A10BK01
ATC
dapagliflozin; oral
1.9
7.0
92
485
C10AA01
ATC
simvastatin; oral
1.3
7.0
885
7565
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
4.9
7.0
21
43
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.9
7.0
40
139
R51.80
ICD-10 Finland
Headache
1.5
7.0
248
1730
E66.8
ICD-10 Finland
Other obesity
1.9
6.9
93
491
JN4BD
NOMESCO Finland
Extensive body CT
1.5
6.9
209
1405
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.9
6.9
99
537
B01AB04
ATC
dalteparin; parenteral
1.9
6.9
97
524
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.5
6.9
49
196
L28
ICPC
Limited function/disability (L)
1.4
6.8
296
2147
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.3
6.8
58
254
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
6.8
751
6302
RS220
NOMESCO Finland
NA
3.4
6.8
30
88
207
Kela drug reimbursment
Chronic arrhythmias
1.4
6.8
287
2071
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.8
6.8
41
150
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
40.2
6.8
8
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
6.7
211
1431
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
6.6
326
2417
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.0
6.6
76
380
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.2
6.6
64
299
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
6.5
339
2539
E66.00
ICD-10 Finland
Metabolic syndrome
1.8
6.5
104
587
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
3.2
6.5
32
102
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
6.5
277
2001
TPH00
SPAT
NA
70.0
6.4
7
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.1
6.4
66
317
A06AD11
ATC
lactulose; oral
1.4
6.4
266
1912
316
Kela drug reimbursment
Imatinib
14.3
6.4
10
7
3AC01
NOMESCO Finland
NA
3.5
6.4
27
77
WX780
NOMESCO Finland
Remote monitoring CPAP
2.0
6.4
74
371
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.8
6.4
25
67
XF402
NOMESCO Finland
ECG with work load test
1.5
6.4
221
1531
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.0
6.3
74
373
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
6.3
334
2514
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
9.3
6.3
12
13
D68.8
ICD-10 Finland
Other specified coagulation defects
4.0
6.3
23
58
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.0
6.3
71
352
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.6
6.3
43
170
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
6.3
101
571
N05BA01
ATC
diazepam; systemic, rectal
1.4
6.2
253
1812
A02BC05
ATC
esomeprazole; systemic
1.3
6.2
786
6690
XW000
SPAT
NA
26.7
6.2
8
*
A02BC01
ATC
omeprazole; systemic
1.3
6.2
522
4218
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
6.2
737
6228
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
6.2
202
1382
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.8
6.2
101
576
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
6.2
287
2108
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
6.2
135
838
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.8
6.2
36
128
C08CA02
ATC
felodipine; oral
1.5
6.2
180
1202
ZX108
NOMESCO Finland
Inhalation
5.0
6.2
18
36
A91
ICPC
Abnormal result investigation NOS
1.9
6.2
81
427
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
6.1
413
3230
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.5
6.1
191
1294
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
6.1
311
2322
M54.5
ICD-10 Finland
Low back pain
1.3
6.1
605
4993
160
Kela drug reimbursment
exenatide
2.5
6.1
45
185
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.2
6.1
29
91
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
12.5
6.1
10
8
J01MA14
ATC
moxifloxacin; systemic
1.6
6.1
159
1032
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.8
6.1
98
557
E66.9
ICD-10 Finland
Obesity, unspecified
2.1
6.1
63
304
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.1
732
6193
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.7
6.0
120
726

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022096) Basophils/100 leukocytes in Blood
1938
9457
5.20
314.53
13.0
5.9
%
0.9
0.7
29.43
1850
8809
(3019069) Monocytes/100 leukocytes in Blood
1964
9763
5.22
308.84
13.6
6.1
%
8.8
8.7
0.55
1876
9119
(3006504) Eosinophils/100 leukocytes in Blood
1958
9720
5.19
308.17
13.0
5.8
%
2.8
2.8
0.75
1869
9038
(3023520) Reticulocytes [#/volume] in Blood
826
1755
6.45
307.65
3.8
2.6
e9/l
79.8
70.0
8.16
597
1330
(42870588) Differential panel, method unspecified - Blood
1654
7066
4.73
307.65
12.3
5.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
462
184
30.36
307.65
1.2
1.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
999
2377
6.22
307.65
3.4
2.5
%
1.8
1.8
0.38
875
2095
(21494434) Karyotype in Bone marrow
323
178
20.60
307.65
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
751
214
49.06
307.65
1.1
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
775
333
32.82
307.65
1.4
1.2
u/l
25.5
38.0
0.94
684
289
(3042111) Morphology [Interpretation] in Bone marrow Narrative
518
316
20.25
307.65
1.6
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1256
2353
9.44
307.65
7.4
4.0
u/l
262.6
245.1
2.43
1196
2224
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
948
2825
4.72
295.09
2.8
2.6
%
24.7
22.8
3.10
844
2424
(3002030) Lymphocytes/100 leukocytes in Blood
1969
10012
5.06
294.78
13.4
5.9
%
27.2
27.4
0.31
1880
9306
(3006315) Basophils [#/volume] in Blood
2000
10407
5.08
287.16
11.9
5.6
e9/l
0.1
0.0
30.54
1817
8952
(3018010) Neutrophils/100 leukocytes in Blood
1936
9873
4.83
284.46
12.5
5.7
%
57.9
57.7
0.26
1836
9214
(3001604) Monocytes [#/volume] in Blood
1987
10364
4.97
282.28
11.9
5.6
e9/l
0.6
0.6
7.42
1809
8910
(3013115) Eosinophils [#/volume] in Blood
2023
10779
5.04
276.99
13.0
5.8
e9/l
0.2
0.2
3.04
1861
9405
(3004789) Transferrin [Mass/volume] in Serum or Plasma
963
3034
4.47
276.23
2.7
2.5
g/l
2.4
2.3
8.63
898
2816
(3019198) Lymphocytes [#/volume] in Blood
2003
10652
4.92
273.34
12.0
5.7
e9/l
2.1
1.9
1.51
1857
9333
(3022948) Iron [Moles/volume] in Serum or Plasma
978
3279
4.19
254.76
2.8
2.5
umol/l
14.5
13.0
6.86
917
3044
(3013650) Neutrophils [#/volume] in Blood by Automated count
2073
12131
4.58
227.27
17.6
8.6
e9/l
4.7
4.2
7.73
1893
10549
(3026493) Urate [Moles/volume] in Serum or Plasma
1224
5676
3.20
180.32
3.9
2.6
umol/l
2118.7
5648.5
3.25
1100
4912
(3017181) Myelocytes/100 leukocytes in Blood
579
1722
4.04
171.01
7.8
4.0
%
1.1
0.8
2.36
221
497
(3002179) Metamyelocytes/100 leukocytes in Blood
547
1576
4.13
168.68
7.6
3.8
%
1.0
0.5
2.35
187
355
(3025159) Blasts/100 leukocytes in Blood
527
1542
4.04
158.38
8.1
4.1
%
0.9
0.3
0.66
188
384
(3021440) Promyelocytes/100 leukocytes in Blood
545
1643
3.94
156.91
7.7
4.1
%
0.1
0.1
0.45
211
463
(3021589) Normoblasts [#/volume] in Blood
1590
9244
2.87
144.76
18.5
9.4
e9/l
0.0
0.0
3.71
1380
7534
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
291
600
5.34
135.11
2.9
2.3
g/l
3.2
3.6
4.30
280
566
(40760892) CBC W Ordered Manual Differential panel - Blood
967
4500
2.84
132.66
8.8
4.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1755
11047
2.83
131.78
9.1
6.1
umol/l
12.2
11.6
1.13
1700
10476
(3032868) Hemoglobin electrophoresis panel in Blood
80
21
39.28
130.58
1.4
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1464
8626
2.61
121.93
4.0
2.8
ug/l
149.7
136.4
0.62
1341
7933
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
221
412
5.77
114.19
4.4
3.6
%
59.2
58.0
0.61
221
412
(3030905) Polymorphonuclear cells [#/volume] in Blood
209
401
5.58
104.54
3.7
3.3
e9/l
4.6
4.2
1.05
209
401
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
323
954
3.73
93.20
2.3
1.8
g/l
1.2
1.5
7.66
278
825
(3018418) pH of Serum or Plasma
1095
6224
2.32
90.44
6.0
3.9
ph
7.4
7.4
2.02
282
1181
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2138
16367
2.77
85.71
13.3
7.4
u/l
82.2
78.4
3.19
2057
15390
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
50
11
46.33
84.79
2.5
4.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
226
560
4.33
82.97
3.2
3.2
mg/l
1.4
1.6
3.70
210
511
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1456
9593
2.19
80.52
8.1
6.0
mmol/l
1.2
1.2
3.22
1328
8653
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1556
10531
2.20
80.26
8.6
6.8
mmol/l
1.2
1.2
0.42
1248
8872
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
949
5295
2.25
79.60
2.8
2.2
mg/l
4.1
3.0
9.38
808
4489
(3000093) Morphology [Interpretation] in Blood Narrative
121
177
7.12
79.12
1.2
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
237
652
3.90
75.31
2.8
2.0
%
92.0
90.9
0.33
208
619
(4212803)
49
17
29.36
73.43
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
383
1452
2.92
72.56
3.5
2.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
237
673
3.78
71.89
4.5
3.7
mg/l
47.9
67.4
0.87
205
545
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
233
655
3.81
71.71
4.4
3.7
ratio
5.5
2.5
0.33
19
59
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
45
13
35.21
71.20
1.1
1.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
236
676
3.74
70.66
4.5
3.7
mg/l
38.4
81.6
1.30
205
550
(3020630) Protein [Mass/volume] in Serum or Plasma
424
1738
2.72
69.10
3.4
2.8
g/l
66.8
66.4
0.51
380
1596
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
237
698
3.64
68.04
4.5
2.6
g/l
1.6
1.1
0.87
212
615
(3024561) Albumin [Mass/volume] in Serum or Plasma
1372
9218
2.04
67.42
6.2
4.8
g/l
35.4
35.4
0.03
1271
8564
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
220
620
3.79
67.38
4.6
2.4
g/l
0.0
0.0
0.21
203
574
(3005719) IgG [Mass/volume] in Serum or Plasma
384
1516
2.80
67.18
2.9
2.7
g/l
10.3
10.7
0.94
344
1382
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
518
2371
2.48
67.10
4.3
2.7
umol/l
7.8
8.4
0.28
457
2082
(40758558) Short blood count panel - Blood
917
5335
2.11
66.64
12.8
6.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
246
767
3.44
64.63
4.3
2.6
g/l
3.1
3.1
0.11
198
615
(3028026) IgM [Mass/volume] in Serum or Plasma
323
1192
2.95
63.87
2.1
1.8
g/l
1.5
1.4
0.26
294
1095
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
207
580
3.79
63.87
4.4
2.4
g/l
0.0
0.0
0.00
190
537
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
218
641
3.62
62.62
4.3
2.3
g/l
38.3
37.7
0.82
195
560
(3033658) Prothrombin time (PT) actual/Normal
913
5406
2.07
62.42
6.2
3.9
%
85.8
89.0
2.92
874
5278
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
203
574
3.75
61.77
4.5
2.4
g/l
0.0
0.0
0.00
190
536
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
251
820
3.28
61.10
4.3
2.5
g/l
3.7
3.8
0.33
199
598
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
251
821
3.28
60.98
4.3
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
251
821
3.28
60.98
4.3
2.5
g/l
7.0
7.3
1.89
202
625
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
182
492
3.90
59.03
1.6
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
236
768
3.28
57.74
4.2
2.6
g/l
10.9
10.3
0.95
202
662
(3013826) Glucose [Moles/volume] in Serum or Plasma
1676
12476
1.98
57.24
6.9
4.9
mmol/l
6.8
6.8
0.11
1615
11719
(3003458) Phosphate [Moles/volume] in Serum or Plasma
557
2835
2.23
55.46
6.2
5.8
mmol/l
1.1
1.0
0.58
529
2625
(3013707) Erythrocyte sedimentation rate by Westergren method
1949
15509
2.04
52.24
5.0
4.0
mm/h
12.5
12.3
0.20
1809
14322
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1259
8761
1.85
50.21
2.4
2.0
pmol/l
92.0
95.2
1.58
741
4554
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
193
606
3.36
49.89
3.1
2.2
%
184.6
191.4
0.42
185
576
(40760888) Immunoglobulin light chains.free panel - Serum
174
512
3.57
49.75
3.7
3.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
906
5717
1.90
48.89
3.8
3.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1251
8752
1.83
48.44
12.3
9.6
inr
1.3
1.3
0.08
468
2486
(3002582) Erythrocytes [#/volume] in Urine
985
6410
1.87
48.08
3.9
3.3
e6/l
86.1
83.7
0.03
780
4968
(40761536) Microorganisms panel - Urine sediment
383
1771
2.36
47.26
4.5
3.9
—
—
—
0
0
(3000012) Reticulocyte production index
71
102
7.13
47.11
1.8
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
915
5859
1.87
46.69
3.8
3.2
e6/l
0.6
0.4
0.57
717
4450
(3037756) Immunofixation for Serum or Plasma
156
459
3.55
44.56
1.6
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
128
330
4.03
44.24
6.3
3.3
%
1.5
1.4
0.14
98
254
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
368
1720
2.33
44.13
4.0
3.7
mmol/l
1.2
1.2
0.45
320
1499
(3021960) Folate [Moles/volume] in Serum or Plasma
795
4955
1.87
43.55
1.8
1.6
nmol/l
20.5
20.5
0.03
704
4230
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
43
38
11.49
41.40
1.0
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
692
4213
1.88
40.28
3.2
2.7
mosm/kgh2o
533.1
552.1
1.53
593
3589
(3036489) Thrombin time
212
799
2.80
39.77
2.8
1.9
s
21.9
21.5
0.36
190
714
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
65
102
6.51
39.72
1.7
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
65
102
6.51
39.72
1.7
1.5
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
573
3300
1.95
39.38
3.0
2.0
s
31.2
29.8
5.24
548
3205
(3018095) Leukocytes [#/volume] in Urine
1068
7449
1.74
39.10
4.6
3.7
e6/l
116.0
110.9
0.07
805
5341
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1000
6862
1.75
38.68
4.3
3.2
u/l
34.9
37.1
0.33
963
6518
(1616796) Gas panel - Central venous blood
151
483
3.26
37.77
4.4
3.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
717
4490
1.83
37.73
3.2
2.6
e6/l
4.4
5.2
1.43
631
3943
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
729
4616
1.81
36.84
2.2
1.7
mg/l
1.2
1.2
0.02
563
3525
(3019309) Folate [Moles/volume] in Red Blood Cells
653
4012
1.84
36.36
1.9
1.8
nmol/l
1135.7
1167.0
0.36
483
3036
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
34
26
13.24
35.72
1.1
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
45
53
8.62
35.28
1.2
1.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
584
3494
1.87
35.25
4.1
3.2
mmol/l
0.8
0.8
0.45
558
3273
(3012501) Base excess in Blood by calculation
148
489
3.15
35.06
5.7
4.6
mmol/l
3.0
2.6
0.51
104
333
(3037522) Nuclear Ab [Titer] in Serum
477
2694
1.95
34.24
1.4
1.3
titre
434.5
516.2
0.57
95
585
(3010421) pH of Blood
161
587
2.86
32.05
5.5
4.2
ph
7.4
7.4
0.75
145
481
(3037467) Urinalysis macro (dipstick) panel - Urine
1747
14371
1.67
30.95
4.8
4.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
603
3772
1.78
30.93
1.8
1.4
g/l
2.5
2.5
0.22
398
2295
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
899
6295
1.66
30.40
3.5
3.1
ng/l
1745.9
1405.1
1.33
745
5369
(3052851) Hemolysis interference index of Serum or Plasma
166
637
2.72
29.97
4.0
3.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
386
2160
1.93
28.05
1.6
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
83
222
3.83
27.27
6.8
3.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2319
20937
2.05
27.08
24.5
14.4
mg/l
20.3
24.6
9.82
2011
16600
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
107
342
3.22
26.79
1.3
1.4
u/ml
105.1
122.1
0.55
17
70
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
393
2253
1.88
26.42
4.2
3.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
113
378
3.08
26.21
1.3
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
125
453
2.85
25.15
3.4
2.5
%
18.0
16.1
3.02
69
232
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
146
574
2.64
25.11
1.8
1.5
g/l
0.2
0.2
0.03
133
543
(3023368) Bacteria identified in Blood by Culture
824
5881
1.59
24.60
5.8
4.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
968
7170
1.56
24.57
3.4
3.3
mmol/l
2.3
2.4
1.00
843
6238
(3036481) Cortisol [Moles/volume] in Serum or Plasma
338
1892
1.90
24.34
2.5
2.1
nmol/l
356.2
370.4
0.72
321
1733
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
30
8
37.93
23.94
7.4
11.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
769
5431
1.59
23.86
3.8
3.3
—
—
—
0
0
(4035726)
326
1816
1.91
23.80
1.4
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
130
496
2.71
23.73
1.6
1.4
u/l
8.1
9.1
0.46
100
407
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
419
2529
1.78
23.63
1.6
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
535
3459
1.69
23.60
2.2
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
888
6504
1.56
23.42
3.6
3.3
mg/l
720.5
300.0
1.26
563
4166
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
146
599
2.52
23.01
1.8
1.5
g/l
1.2
1.2
0.58
134
566
(3047189) Immunofixation for 24 hour Urine
48
97
5.02
22.55
2.0
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1285
10245
1.51
22.51
3.9
3.7
estimate
0.0
0.0
1.08
376
1828
(3035350) Ketones [Presence] in Urine by Test strip
1271
10114
1.51
22.45
3.8
3.6
estimate
0.0
0.0
0.00
392
1861
(3002385) Erythrocyte distribution width [Ratio]
1974
17264
1.61
22.42
34.2
17.5
%
14.7
13.7
67.28
1952
16854
(3021601) Nitrite [Presence] in Urine by Test strip
1272
10128
1.50
22.37
5.1
4.9
estimate
0.0
0.0
0.50
393
1902
(3020682) Albumin/Creatinine [Ratio] in Urine
921
6855
1.53
22.32
4.6
4.0
mg/mmol
14.1
8.9
1.81
558
4366
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
106
376
2.90
22.19
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
261
1388
1.98
21.78
5.5
3.1
e9/l
4.8
4.1
2.40
173
1069
(3021879) Hepatitis B virus core Ab [Presence] in Serum
260
1381
1.98
21.77
1.4
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
916
6855
1.52
21.42
3.7
3.2
mmol/l
7.8
7.6
0.63
734
5764
(3020779) Urea [Moles/volume] in Serum or Plasma
337
1964
1.82
21.23
8.1
7.6
mmol/l
9.7
10.0
0.31
318
1871
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
340
1991
1.81
21.07
2.5
2.4
u/l
33.9
62.4
0.63
300
1709
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1094
8517
1.49
21.03
2.7
2.2
nmol/l
76.6
77.3
0.36
974
7601
(46235355) HIV 1 and 2 tests - Meaningful Use set
474
3051
1.68
21.01
1.7
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2200
19873
1.72
20.90
25.0
13.5
ml/min/173m2
78.6
79.8
1.76
1948
16432
(3044889) 12 lead EKG panel
1752
15022
1.52
20.70
4.7
3.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
74
222
3.40
20.55
2.3
2.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
244
1293
1.98
20.54
3.8
3.6
mmol/l
2.5
1.8
1.91
176
955
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
343
2041
1.78
20.10
2.5
2.2
g/l
0.2
0.2
0.22
313
1913
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
871
6526
1.50
19.91
2.3
2.1
u/l
189.2
228.9
0.69
805
6131
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
509
3380
1.63
19.87
3.4
3.0
e6/l
2.1
2.1
0.09
285
1843
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
580
3977
1.59
19.82
3.4
3.1
mmol/l
2.5
2.5
0.17
494
3499
(3031040) Bacteria [#/volume] in Urine by Automated count
1613
13658
1.48
19.76
5.2
4.5
e6/l
136.7
1616.5
2.16
18
198
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
96
354
2.78
18.74
1.3
1.2
u/ml
260.1
257.9
0.03
65
223
(3017354) Segmented neutrophils/100 leukocytes in Blood
69
211
3.33
18.62
7.0
3.0
%
62.8
56.8
1.02
40
134
(3009343) pH of Capillary blood
245
1348
1.90
18.42
4.0
3.6
ph
7.4
7.4
0.31
56
168
(3007853) Bacteria identified in Skin by Aerobe culture
389
2456
1.69
18.36
2.1
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1811
15802
1.49
18.24
4.5
3.9
pmol/l
15.0
14.8
2.35
1617
14307
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
247
1367
1.89
18.23
4.0
3.6
kpa
5.3
5.2
1.61
229
1266
(3019550) Sodium [Moles/volume] in Serum or Plasma
2343
21718
1.85
18.17
27.0
16.8
mmol/l
139.4
139.7
4.97
2298
21161
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2112
19069
1.59
17.88
5.5
4.7
mu/l
1.9
2.2
0.99
1923
17373
(40768797) Stomach Pathology biopsy report
448
2957
1.62
17.73
1.2
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
128
558
2.36
17.70
1.2
1.2
titre
586.0
1283.7
—
5
19
(3000060) B lymphocytes [#/volume] in Blood
27
40
6.81
17.42
1.9
2.1
e6/l
1276.5
163.9
0.48
17
18
(3000991) Gas panel - Venous blood
304
1820
1.76
17.34
10.4
8.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2344
21787
1.82
17.21
28.3
16.9
mmol/l
4.0
4.0
1.68
2292
21198
(3015235) Bicarbonate [Moles/volume] in Capillary blood
128
565
2.33
17.21
3.8
3.2
mmol/l
25.7
24.9
1.05
123
493
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
155
742
2.16
17.14
4.0
3.0
u/ml
0.4
0.3
0.17
93
410
(3007566) Smooth muscle Ab [Titer] in Serum
126
556
2.33
16.95
1.2
1.2
titre
521.7
86.7
—
6
46
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1594
13679
1.43
16.67
4.0
3.2
u/l
61.4
51.2
3.65
1496
12716
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
190
995
1.98
16.50
5.4
3.8
mmol/l
23.9
24.1
0.37
172
887
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
101
408
2.54
16.49
6.0
5.2
iu/ml
870.9
784.5
0.04
11
57
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
375
2408
1.65
16.48
2.1
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
860
6637
1.44
16.10
2.8
2.6
u/l
52.7
57.7
4.60
781
6122
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1025
8171
1.42
16.03
4.4
3.7
ng/l
31.2
106.9
0.77
778
5749
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
375
2424
1.64
16.03
2.1
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
214
1179
1.89
15.99
3.0
3.4
pmol/l
4.4
4.5
0.09
175
1040
(3048929) Epstein Barr virus Ab [Presence] in Serum
122
545
2.30
15.97
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
126
572
2.26
15.88
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1055
8465
1.42
15.85
2.3
2.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
99
405
2.50
15.75
3.3
2.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
85
323
2.69
15.70
1.2
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
449
3045
1.57
15.70
2.2
2.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
279
1683
1.74
15.44
3.7
2.2
nmol/l
13.1
13.1
0.01
252
1490
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2137
19517
1.55
15.39
7.1
5.9
mmol/mol
40.2
40.1
0.21
1969
18020
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
16
14
11.49
15.32
1.5
1.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
386
2542
1.61
15.26
8.6
7.7
kpa
11.2
12.2
2.94
378
2419
(3014111) Lactate [Moles/volume] in Serum or Plasma
308
1917
1.69
15.20
8.7
7.3
mmol/l
1.5
1.4
0.70
300
1848
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
45
119
3.83
15.12
1.8
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
585
4234
1.49
15.08
4.7
3.8
ng/l
586.3
433.3
0.14
475
3369
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
385
2542
1.60
15.04
8.7
7.7
kpa
5.2
5.1
1.05
378
2421
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
211
1181
1.86
15.00
10.6
10.0
mmol/l
24.3
24.3
0.06
206
1104
(3044640) Blood type and Crossmatch panel - Blood
857
6678
1.42
14.96
4.2
2.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
508
3600
1.51
14.43
3.3
2.8
e6/l
0.9
1.1
0.67
290
2049
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2172
19981
1.55
14.35
4.9
4.0
mmol/l
1.5
1.3
12.86
2005
18198
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
27
49
5.56
14.30
1.1
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
46
129
3.61
14.23
1.2
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
379
2531
1.58
14.06
8.8
7.8
mmol/l
1.1
1.0
0.15
312
1975
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
252
1525
1.72
13.75
2.0
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
715
5474
1.42
13.50
4.2
4.0
estimate
0.0
0.0
1.28
370
1829
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
44
125
3.56
13.37
1.9
1.9
%
13.2
14.1
0.15
27
55
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
57
191
3.03
13.30
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
81
328
2.52
13.21
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
62
220
2.86
13.08
1.7
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
52
168
3.14
12.92
2.0
2.1
e9/l
1.2
1.1
0.31
32
94
(40765096) Chromosome analysis panel by Banding
30
66
4.59
12.82
1.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2369
22362
1.71
12.79
19.3
10.4
u/l
29.0
26.8
3.41
2298
21550
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
58
201
2.93
12.78
2.3
2.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
99
449
2.25
12.56
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
99
449
2.25
12.56
1.6
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
57
198
2.92
12.51
1.2
1.2
u/l
64.8
51.7
0.76
42
136
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
97
437
2.27
12.50
1.5
1.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
68
261
2.65
12.38
1.6
1.4
mu/l
93.5
59.7
0.53
58
232
(40758292) HTLV I+II Ab panel - Serum
19
28
6.83
12.30
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
349
2357
1.56
12.24
1.3
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
783
6193
1.38
11.94
3.4
3.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2218
20688
1.51
11.74
5.4
4.4
mmol/l
1.3
1.4
64.26
2058
18972
(3022493) Free Hemoglobin [Mass/volume] in Plasma
33
84
3.97
11.73
1.4
8.0
mg/l
7465.2
64.4
0.49
25
58
(3024471) HLA-A [Type]
30
71
4.26
11.73
1.0
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
108
522
2.12
11.71
2.0
2.1
mg/l
15.8
12.0
1.00
96
476
(3020876) Protein [Mass/time] in 24 hour Urine
51
173
2.99
11.69
1.9
2.1
g/24h
1.8
1.9
—
5
10
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
64
246
2.64
11.64
1.3
1.4
pmol/l
354.3
274.2
0.91
55
193
(3051611) Lipemic interference index of Serum or Plasma
58
212
2.78
11.62
4.4
3.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
950
7777
1.35
11.54
3.9
3.9
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
76
320
2.42
11.45
1.3
1.2
u/ml
2.1
4.1
0.93
28
109
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
125
645
1.99
11.36
2.3
1.9
nmol/l
34.9
39.5
1.43
120
621
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
73
304
2.44
11.27
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
358
2475
1.52
11.24
1.6
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
334
2281
1.53
11.09
9.3
8.2
%
94.1
95.6
3.58
328
2194
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
118
602
2.01
11.08
1.8
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
66
265
2.53
11.01
1.4
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2226
20839
1.49
10.94
5.5
4.5
mmol/l
4.3
4.6
42.25
2084
19225
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
46
153
3.04
10.93
1.1
1.2
titre
194.0
198.1
—
10
31
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
40
123
3.29
10.81
2.0
2.2
e6/l
651.1
552.7
0.34
30
105
(3010375) cycloSPORINE [Mass/volume] in Blood
34
94
3.65
10.79
29.4
27.6
ug/l
114.7
123.7
0.36
29
75
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
26
59
4.44
10.73
1.2
1.1
%
68.8
94.0
2.40
16
33
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1159
9852
1.32
10.59
6.3
4.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2259
21245
1.50
10.51
6.0
5.0
mmol/l
2.5
2.7
20.71
2101
19493
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
23
48
4.83
10.48
1.3
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
295
1985
1.55
10.46
4.8
3.6
kpa
5.8
5.8
0.11
283
1921
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
717
5689
1.36
10.46
1.7
1.7
mmol/l
1.6
1.4
4.78
564
4778
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
75
328
2.33
10.41
1.3
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
78
348
2.28
10.34
1.9
1.6
—
—
—
0
0
(3013512) EKG study
782
6297
1.35
10.33
4.2
3.9
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
40
127
3.18
10.28
4.1
3.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
38
117
3.28
10.26
2.1
2.2
e9/l
0.3
0.2
0.26
29
104
(3002032) Base excess in Venous blood by calculation
293
1977
1.54
10.26
4.8
3.6
mmol/l
1.7
1.9
0.56
233
1571
(3006184) Hemoglobin [Mass/volume] in Capillary blood
98
481
2.08
10.25
2.6
2.2
g/l
148.1
129.1
6.46
81
353
(3024932) HLA-DR beta [Type]
28
70
4.03
10.22
1.3
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
657
5161
1.37
10.17
4.2
2.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
25
58
4.34
10.05
1.2
1.4
%
77.3
89.2
0.55
16
33
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
22
46
4.82
10.01
1.1
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
43
145
3.00
10.00
1.9
2.2
e6/l
1070.1
719.7
0.61
11
59
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
207
1296
1.65
9.93
1.9
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
54
207
2.64
9.92
2.2
2.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
71
310
2.33
9.91
1.3
1.2
u/ml
5.6
5.4
0.04
34
131
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
27
68
4.00
9.77
1.2
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
98
490
2.04
9.77
1.9
1.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
14
19
7.40
9.70
1.4
1.5
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
14
19
7.40
9.70
1.1
1.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
134
748
1.83
9.65
3.1
2.2
ug/l
538.2
499.9
0.06
127
703
(3004451) EKG impression Narrative
34
102
3.36
9.58
1.1
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
95
473
2.05
9.58
1.9
1.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
151
877
1.77
9.54
1.8
1.9
u/l
40.1
38.4
0.49
126
771
(3019060) Gas panel - Arterial blood
224
1445
1.60
9.52
5.1
5.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
274
1860
1.53
9.32
3.1
3.0
ng/l
241.8
201.5
0.90
250
1693
(3022217) INR in Platelet poor plasma by Coagulation assay
390
2858
1.43
9.00
31.5
26.0
inr
1.6
1.4
2.33
56
405
(3002256) Pathology report gross observation
371
2696
1.44
8.97
1.3
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
242
1613
1.55
8.94
4.4
3.9
ng/l
91.2
92.2
0.06
206
1403
(3024980) IgG subclass 4 [Mass/volume] in Serum
67
302
2.25
8.72
1.7
1.6
g/l
0.8
0.8
0.05
49
230
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
18
36
5.03
8.61
1.2
1.2
%
77.0
82.3
0.25
11
13
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
18
36
5.03
8.61
1.2
1.2
%
78.8
79.3
0.01
11
12
(3003181) Sodium [Moles/volume] in Urine
78
378
2.10
8.49
1.3
1.4
mmol/l
55.9
62.2
0.81
66
302
(3021387) Prolactin [Units/volume] in Serum or Plasma
105
567
1.89
8.43
1.9
1.7
mu/l
267.8
284.6
0.37
98
518
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
65
294
2.24
8.41
1.1
1.1
%
109.4
115.8
0.75
56
272
(3016038) Potassium [Moles/volume] in Urine
39
138
2.85
8.38
1.1
1.1
mmol/l
29.8
33.6
0.56
33
124
(3023323) Follitropin [Units/volume] in Serum or Plasma
123
701
1.79
8.31
1.6
1.4
iu/l
19.3
28.7
3.66
107
600
(3000570) Elastase.pancreatic [Mass/mass] in Stool
110
606
1.85
8.30
1.5
1.4
ug/g
286.8
281.0
0.10
62
349
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
74
357
2.10
8.16
1.2
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2286
21743
1.45
8.09
22.0
13.6
—
—
—
0
0
(4306422)
65
299
2.20
8.08
1.3
1.2
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
11
5
22.08
8.01
2.4
2.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
23
60
3.86
7.97
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
26
74
3.54
7.97
1.1
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
108
600
1.83
7.95
2.0
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
129
756
1.74
7.94
1.2
1.2
u/ml
0.2
1.2
—
7
60
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
22
56
3.95
7.88
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
62
283
2.22
7.87
1.6
1.6
—
—
—
0
0
(3000492) Spirometry study
282
2000
1.46
7.72
1.6
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
56
247
2.30
7.71
2.0
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2031
18991
1.32
7.70
30.7
15.4
%
41.3
39.8
7.93
1363
13373
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
23
62
3.73
7.62
1.3
1.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
212
1425
1.53
7.55
11.8
9.5
%
92.1
93.9
2.85
212
1417
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
35
124
2.85
7.53
1.5
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
185
1208
1.57
7.49
12.1
10.9
—
—
—
0
0
(4062490)
46
189
2.46
7.42
1.3
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
64
304
2.13
7.38
1.1
1.1
g/l
1.5
1.5
0.06
56
270
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
55
246
2.26
7.35
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
73
369
2.01
7.15
3.1
3.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
538
4303
1.32
7.05
1.3
1.2
u/ml
1.7
1.5
0.17
127
1119
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
51
226
2.28
6.98
1.2
1.1
%
90.7
96.9
0.79
46
215
(3025941) Bacteria identified in Stool by Culture
172
1125
1.57
6.93
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2161
20469
1.34
6.91
5.4
4.6
mmol/l
6.1
6.0
4.27
1940
18575
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
33
120
2.77
6.80
1.7
1.6
u/l
6.0
6.7
0.09
20
60
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
334
2499
1.39
6.77
1.8
1.8
%
1.5
1.5
0.66
280
2194
(3048689) Calprotectin [Mass/mass] in Stool
317
2355
1.39
6.71
2.3
2.3
ug/g
130.7
146.2
0.31
251
1880
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
10
14
7.17
6.70
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
50
224
2.26
6.68
1.2
1.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
44
187
2.38
6.63
1.3
1.4
g/l
0.3
0.4
0.20
28
129
(3027135) IgG subclass 1 [Mass/volume] in Serum
44
187
2.38
6.63
1.3
1.4
g/l
8.7
6.8
0.68
28
130
(3028192) IgG subclass 2 [Mass/volume] in Serum
44
187
2.38
6.63
1.3
1.4
g/l
2.9
2.8
0.02
27
129
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
29
100
2.92
6.58
1.2
1.1
u/l
129.2
80.7
1.41
23
75
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
36
140
2.59
6.54
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
36
140
2.59
6.54
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
36
140
2.59
6.54
1.2
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
29
101
2.89
6.47
1.2
1.1
u/l
46.7
21.2
0.71
24
72
(4268621)
47
209
2.27
6.41
2.4
2.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
144
921
1.60
6.40
1.3
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
564
4596
1.29
6.36
1.7
1.7
pmol/l
43678632.7
25210295.6
0.32
435
3812
(40762365) Oxygen content in Arterial blood by calculation
17
42
4.07
6.35
2.8
2.8
ml/dl
14.8
14.6
0.07
17
37
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
36
143
2.54
6.28
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
36
143
2.54
6.28
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
36
143
2.54
6.28
1.2
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
38
156
2.46
6.19
1.4
1.9
nmol/l
17.3
18.1
0.20
38
143
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
57
280
2.06
6.09
1.4
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
102
607
1.71
6.02
1.3
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
12
24
5.02
5.74
1.8
2.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
31
121
2.58
5.63
1.2
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
73
403
1.84
5.58
1.3
1.2
u/ml
23.3
48.2
—
6
42
(3017569) Oxygen content in Arterial blood
29
110
2.65
5.57
1.9
2.5
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
11
21
5.26
5.52
1.0
1.3
mmol/l
188.5
154.3
0.27
11
16
(3019977) pH of Arterial blood
30
118
2.56
5.37
2.6
3.0
ph
7.4
7.4
0.20
20
38
(3024354) Oxygen [Partial pressure] in Venous blood
224
1630
1.41
5.36
3.7
2.9
kpa
5.1
4.6
2.21
212
1574
(3023183) Ammonium ion [Moles/volume] in Plasma
82
478
1.74
5.25
4.5
2.9
umol/l
36.8
37.6
0.08
68
406
(3022313) Gas panel - Capillary blood
147
991
1.51
5.23
3.9
3.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
65
355
1.85
5.17
1.5
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
127
834
1.55
5.10
3.9
3.9
mmol/l
24.8
24.9
0.09
109
779
(46236302) HLA-C [Type] by High resolution typing
8
6
13.37
5.08
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
8
6
13.37
5.08
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
8
6
13.37
5.08
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
8
6
13.37
5.08
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
8
6
13.37
5.08
1.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
27
104
2.61
5.06
3.3
2.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
111
713
1.58
4.92
2.2
2.8
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
45
221
2.05
4.87
1.6
1.5
nmol/l
0.2
0.3
0.45
33
169
(3024891) Influenza virus A+B Ag [Presence] in Specimen
90
551
1.66
4.85
1.3
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
11
24
4.60
4.78
1.4
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
85
515
1.67
4.77
1.3
1.2
u/ml
4.9
8.4
—
8
81
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
46
230
2.02
4.76
3.2
3.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
30
126
2.40
4.72
1.5
2.9
%
38.8
41.6
—
6
39
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
35
158
2.23
4.69
1.6
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
97
611
1.61
4.68
1.9
1.8
—
—
—
0
0
(3016750) Collection duration of Urine
31
135
2.31
4.52
2.3
2.0
min
493.2
481.2
0.22
19
95
(3007461) Platelets [#/volume] in Blood
2392
23255
1.38
4.51
40.4
21.2
e9/l
332.0
247.7
115.88
2355
22631
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
83
508
1.65
4.50
1.3
1.2
u/ml
37.5
3.2
—
9
48
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
24
93
2.60
4.47
2.8
3.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
53
286
1.87
4.42
2.5
2.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
2392
23264
1.38
4.41
40.3
21.1
fl
93.1
91.2
22.35
2368
22899
(3035941) MCH [Entitic mass]
2392
23265
1.38
4.40
40.2
21.0
pg
30.8
30.4
7.84
2368
22898
(3027923) C peptide [Moles/volume] in Serum or Plasma
28
118
2.39
4.40
1.5
1.4
nmol/l
1.8
1.2
1.20
21
91
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
18
60
3.01
4.39
1.7
1.2
%
20.3
15.9
—
6
10
(3026361) Erythrocytes [#/volume] in Blood
2392
23267
1.38
4.38
40.4
21.1
e12/l
4.6
4.5
12.60
2348
22570
(3005322) IgE [Units/volume] in Serum or Plasma
170
1224
1.42
4.36
1.4
1.3
u/ml
222.4
224.7
0.01
156
1131
(3001964) Herpes simplex virus Ag [Presence] in Specimen
17
55
3.10
4.36
1.8
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
19
66
2.89
4.33
1.4
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2392
23273
1.37
4.32
40.5
21.2
e9/l
8.0
6.7
22.24
2350
22575
(3000963) Hemoglobin [Mass/volume] in Blood
2392
23274
1.37
4.31
40.8
21.3
g/l
139.9
135.8
17.11
2366
22908
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
22
4.56
4.30
1.9
3.2
u/field
0.3
0.6
—
10
22
(3003338) MCHC [Mass/volume]
1658
17594
0.84
4.28
37.1
18.6
g/l
330.2
332.6
12.28
1649
17445
(3026389) Candida sp identified in Specimen by Organism specific culture
50
269
1.88
4.23
1.3
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
24
96
2.51
4.21
1.5
1.2
%
70.0
70.0
—
6
15
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
38
186
2.06
4.20
1.1
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
27
115
2.36
4.16
1.2
1.2
ratio
1.1
1.0
—
10
45
(40768446) Kidney Pathology biopsy report
21
79
2.67
4.15
1.3
1.7
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
36
174
2.08
4.11
2.5
2.2
ml
613.7
618.3
0.02
23
112
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
26
110
2.38
4.07
1.4
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
76
468
1.64
4.06
1.5
1.4
e6/l
13.9
30.5
0.60
66
360
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
76
468
1.64
4.06
1.5
1.4
e6/l
718.2
1272.8
0.33
68
379
(44790048)
45
239
1.90
3.97
1.7
1.5
—
—
—
0
0
(44806118)
45
239
1.90
3.97
1.7
1.5
—
—
—
0
0
(44790049)
45
239
1.90
3.97
1.7
1.5
—
—
—
0
0
(44790047)
45
239
1.90
3.97
1.7
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
22
87
2.54
3.96
1.1
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
21
82
2.57
3.88
3.2
2.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
818
7273
1.18
3.75
3.6
2.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
63
379
1.68
3.70
1.3
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
25
110
2.29
3.61
1.4
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
33
164
2.03
3.55
1.6
1.7
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
6
6
10.02
3.49
1.8
2.0
mmol/l
26.3
18.7
—
6
6
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
414
3477
1.23
3.48
1.3
1.3
iu/ml
32.9
35.2
0.10
131
1103
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
32
160
2.01
3.39
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
28
133
2.12
3.39
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
57
344
1.67
3.34
1.2
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
73
470
1.57
3.31
5.0
2.8
—
—
—
0
0
(4010399)
197
1524
1.32
3.27
1.6
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
48
278
1.74
3.27
1.4
1.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
7
8.59
3.26
1.3
2.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
23
103
2.24
3.22
5.6
3.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
106
744
1.44
3.20
1.5
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
272
2201
1.26
3.20
3.3
4.2
ug/l
3.9
16.7
2.78
220
1804
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
15
5.35
3.19
2.0
2.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
93
638
1.47
3.16
1.6
1.6
iu/ml
0.4
10.4
0.48
25
117
(3044290) Cell count panel - Cerebral spinal fluid
68
436
1.57
3.16
1.4
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
36
193
1.88
3.15
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
74
484
1.54
3.15
1.5
1.9
iu/l
2.8
4.9
2.36
24
164
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
40
222
1.81
3.15
1.2
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
165
1255
1.34
3.10
1.3
1.2
iu/ml
136.9
142.3
0.05
51
472
(40768441) Liver Pathology biopsy report
30
152
1.99
3.09
2.0
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
132
1772
0.73
3.09
3.5
3.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
132
2.06
3.06
1.4
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
373
3142
1.22
3.04
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1337
12481
1.15
3.04
3.0
2.8
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
26
127
2.06
2.97
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
26
127
2.06
2.97
1.1
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
69
451
1.54
2.97
3.6
3.2
nmol/l
0.8
0.8
0.06
56
350
(3035320) C reactive protein [Mass/volume] in Body fluid
28
141
2.00
2.95
1.8
2.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
11
35
3.15
2.93
1.3
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
8
17
4.72
2.92
2.3
2.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
39
221
1.78
2.89
1.4
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
51
312
1.65
2.89
1.4
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
14
52
2.70
2.88
1.6
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
79
1142
0.68
2.87
1.4
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
33
179
1.85
2.82
1.2
1.1
u/ml
—
—
—
0
0
(1002224) Polysomnography panel
115
840
1.39
2.82
1.1
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
118
869
1.38
2.76
2.1
1.9
ug/l
1.5
2.2
0.33
102
768
(3023419) Bacteria identified in Sputum by Culture
48
293
1.65
2.75
2.2
2.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
39
225
1.74
2.74
1.3
1.3
mosm/kgh2o
277.9
280.0
0.17
30
165
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
217
2678
0.79
2.74
8.6
7.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
17
72
2.37
2.72
1.5
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
44
264
1.68
2.70
4.2
3.1
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
6
10
6.01
2.70
1.2
1.6
%
1.5
1.4
—
6
10
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
33
183
1.81
2.65
1.0
1.0
mg/l
309.8
285.6
0.96
27
164
(21494814) CD8 cells/100 lymphocytes in Specimen
16
67
2.40
2.63
2.1
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
79
547
1.46
2.62
2.9
2.3
ug/min
135.1
112.5
0.13
43
337
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
28
148
1.90
2.60
1.1
1.1
mg/l
55.3
43.7
0.35
17
120
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
387
3322
1.19
2.60
1.2
1.2
u/ml
14.2
11.4
0.30
125
1298
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
15
4.68
2.59
1.3
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
15
4.68
2.59
1.3
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
8
20
4.01
2.56
1.4
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
135
1753
0.76
2.56
1.4
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
45
277
1.64
2.52
1.2
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
38
224
1.71
2.50
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
118
885
1.35
2.49
5.7
4.5
—
—
—
0
0
(3019225) pH of Specimen
260
2157
1.23
2.49
4.2
4.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
134
1734
0.76
2.48
1.7
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
24
123
1.96
2.45
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
37
218
1.71
2.45
1.4
1.6
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
19
89
2.14
2.44
1.4
2.8
umol/l
66.9
103.3
—
8
52
(3011397) Hemoglobin [Presence] in Urine by Test strip
542
4809
1.16
2.44
3.4
3.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
164
1293
1.29
2.43
1.7
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
53
343
1.56
2.43
1.2
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
77
540
1.44
2.41
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
75
525
1.44
2.38
1.2
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
8
6.26
2.37
1.0
1.1
—
—
—
0
0
(4027681)
22
111
1.99
2.35
1.5
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
35
206
1.71
2.34
1.3
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
621
5581
1.15
2.33
1.5
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
26
141
1.85
2.27
1.6
1.4
u/l
12.6
13.5
0.31
26
134
(3020393) Adenovirus Ag [Presence] in Stool
7
18
3.90
2.25
1.1
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
15
66
2.28
2.24
1.1
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
36
217
1.67
2.22
2.4
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
16
73
2.20
2.21
4.6
4.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
184
1491
1.25
2.21
2.0
1.9
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
13
54
2.41
2.19
1.5
1.8
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
26
143
1.83
2.19
1.1
1.1
mg/l
269.1
291.5
0.25
20
122
(3025130) Human papilloma virus identified in Specimen
34
203
1.68
2.18
1.2
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
105
795
1.33
2.12
2.7
3.4
u/ml
386.7
5150.6
0.76
89
675
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
25
138
1.82
2.09
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
188
1539
1.24
2.07
1.2
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
21
111
1.90
2.00
1.9
1.8
—
10.6
—
0
7
(3014765) Yersinia sp identified in Stool by Organism specific culture
84
621
1.36
2.00
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
155
1248
1.26
1.99
1.6
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
112
867
1.31
1.96
2.3
1.9
—
—
—
0
0
(44806071)
7
21
3.34
1.96
1.1
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
14
64
2.19
1.94
1.6
2.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
103
790
1.32
1.93
2.0
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
84
626
1.35
1.91
1.1
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
168
1376
1.24
1.87
8.4
7.3
mmol/l
25.3
24.5
1.63
163
1274
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
32
197
1.63
1.86
2.5
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
34
2.65
1.86
1.3
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
11
46
2.40
1.85
1.5
1.3
ug/l
0.4
0.4
—
5
29
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
17
86
1.98
1.85
1.1
1.1
%
113.3
93.8
0.58
12
68
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
63
451
1.41
1.84
1.5
2.0
nmol/l
1.1
0.8
1.89
51
375
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
10
40
2.51
1.83
1.3
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
197
1648
1.21
1.80
2.1
2.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
82
616
1.34
1.79
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
18
95
1.90
1.75
1.1
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
32
201
1.60
1.74
1.3
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
19
103
1.85
1.71
2.8
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
19
103
1.85
1.71
2.8
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
19
103
1.85
1.71
2.8
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
19
103
1.85
1.71
2.8
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
55
390
1.42
1.71
5.8
3.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
33
210
1.58
1.71
1.0
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
75
2.01
1.69
3.2
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
75
2.01
1.69
3.2
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
54
384
1.41
1.66
1.6
1.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
6
19
3.16
1.66
1.2
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
31
2.59
1.66
1.1
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
266
0.52
1.66
1.4
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
204
1730
1.19
1.63
2.9
2.7
ml/min/173m2
59.9
64.8
1.25
120
705
(3001556) Androgen free Index in Serum or Plasma
5
14
3.58
1.61
2.0
1.1
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
5
14
3.58
1.61
1.6
1.0
nmol/l
4.4
5.7
—
5
14
(3029075) Extractable nuclear Ab panel - Serum
12
56
2.15
1.61
1.2
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
32
2.50
1.59
3.5
5.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
15
77
1.95
1.59
3.2
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
23
136
1.70
1.58
2.0
1.9
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
28
175
1.61
1.57
1.8
1.4
pmol/l
101.6
69.3
0.42
19
56
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
25
152
1.65
1.56
1.4
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
99
782
1.28
1.55
1.1
1.1
—
1.6
—
0
11
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
40
273
1.47
1.54
1.2
1.1
u/ml
12.5
2.3
0.88
13
112
(3017704) Immunofixation for Urine
22
130
1.70
1.53
1.6
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
95
749
1.28
1.51
3.0
3.2
g/l
0.4
0.3
0.55
52
302
(3034891) Synovial lining cells/100 cells in Synovial fluid
18
101
1.79
1.48
1.5
1.4
%
6.2
4.3
—
5
20
(3009871) Measles virus Ab [Titer] in Serum
14
72
1.95
1.48
1.6
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
41
284
1.45
1.47
1.3
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
253
0.55
1.44
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
253
0.55
1.44
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
820
7685
1.10
1.43
4.5
4.8
ug/l
2.9
3.4
0.22
716
6874
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
252
0.55
1.42
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
252
0.55
1.42
1.3
1.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
20
118
1.70
1.41
1.2
1.1
u/l
1.0
1.2
1.78
11
58
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
14
74
1.90
1.39
1.3
1.2
g/l
0.3
0.3
—
8
61
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
154
1295
1.20
1.39
1.3
1.3
au/ml
33.9
56.6
—
8
54
(3003434) Protein [Mass/volume] in Pleural fluid
40
280
1.44
1.38
1.3
1.5
g/l
28.7
31.8
0.89
34
249
(3020191) Ethanol [Moles/volume] in Serum or Plasma
24
150
1.61
1.38
1.2
1.4
promille
1.0
1.2
0.25
16
114
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
57
427
1.34
1.34
1.5
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
36
509
0.70
1.30
1.2
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
9
43
2.10
1.30
1.1
1.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
34
234
1.46
1.29
1.3
1.4
e6/l
197882.8
87240.3
0.57
23
135
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
44
319
1.39
1.27
1.2
1.1
u/ml
0.6
1.6
1.03
16
128
(3022621) pH of Urine by Test strip
158
1346
1.19
1.26
2.7
3.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
24
154
1.56
1.25
1.2
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
405
4438
0.90
1.25
3.9
4.1
kg/l
1.0
1.0
0.71
75
642
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
16
92
1.74
1.25
1.1
1.2
iu/ml
148.9
211.9
0.74
16
92
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
108
888
1.23
1.24
5.1
5.9
%
2.2
1.6
2.49
103
820
(3004616) Nuclear Ab [Presence] in Serum
35
245
1.43
1.23
1.4
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
65
504
1.30
1.22
1.2
1.2
miu/ml
207.2
216.8
0.08
27
220
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
18
108
1.67
1.22
2.3
2.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
19
301
0.63
1.22
1.3
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
10
49
2.04
1.22
1.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
37
2.17
1.21
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
57
740
0.77
1.21
1.9
1.7
mg/l
4.1
3.9
0.06
47
526
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
27
180
1.51
1.21
2.3
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
27
180
1.51
1.21
2.3
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
27
180
1.51
1.21
2.3
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
32
222
1.45
1.19
1.2
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
26
2.31
1.18
1.0
1.4
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
6
26
2.31
1.18
1.5
1.8
%
5.2
7.0
—
6
13
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
39
281
1.39
1.18
1.1
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
8
38
2.11
1.18
1.0
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
12
64
1.88
1.18
1.7
1.6
%
0.3
3.1
1.72
12
55
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
22
142
1.55
1.14
1.4
1.3
mmol/l
10.3
12.2
0.67
12
48
(3045788) Cell count panel - Pleural fluid
31
216
1.44
1.13
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
12
209
0.57
1.13
1.4
1.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
30
2.34
1.12
1.1
1.5
ng/l
84.1
140.4
—
7
30
(3016018) Differential panel - Cerebral spinal fluid
32
225
1.43
1.12
1.4
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
23
151
1.53
1.11
2.0
1.5
g/l
0.9
1.0
0.18
23
151
(3023199) Leukocytes [#/volume] in Pleural fluid
37
268
1.39
1.10
1.3
1.4
e6/l
1800.9
1729.7
0.04
29
185
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
66
1.82
1.09
1.4
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
481
4455
1.10
1.08
2.9
3.0
ug/l
0.7
0.7
1.70
323
2936
(3044007) Cell count panel - Peritoneal fluid
11
59
1.87
1.07
1.6
2.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
28
194
1.45
1.06
1.2
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
205
0.58
1.06
1.5
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
68
543
1.26
1.05
1.2
1.1
u/ml
36.2
6.2
—
5
60
(3005033) Fetal Nuchal fold Thickness US
12
204
0.59
1.05
1.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
31
220
1.41
1.04
1.6
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
15
90
1.67
1.04
1.5
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
15
90
1.67
1.04
1.5
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
46
1.96
1.03
2.8
2.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
28
197
1.43
1.00
1.5
1.5
%
23.1
29.7
—
10
123
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
13
76
1.71
0.99
1.7
2.2
ug/l
17.9
124.5
0.50
13
66
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
61
1.81
0.98
2.6
2.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
84
1.67
0.97
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
115
980
1.18
0.96
1.2
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
57
452
1.27
0.95
3.5
2.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
105
889
1.19
0.95
3.0
2.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
13
77
1.69
0.95
1.0
1.1
miu/ml
1604.6
1617.8
0.01
13
77
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
37
1.89
0.94
1.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
67
543
1.24
0.94
3.2
2.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
27
2.22
0.93
1.5
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
22
150
1.47
0.93
1.1
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
22
150
1.47
0.93
1.6
1.2
u/ml
0.4
0.9
0.37
12
73
(1761482) Bacteria [#/volume] in Urine by Culture
42
542
0.77
0.91
4.2
4.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
71
584
1.22
0.88
3.1
2.3
—
—
—
0
0
(3035880) pH of Pleural fluid
18
119
1.52
0.88
1.1
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
30
2.00
0.87
1.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
114
982
1.17
0.86
1.1
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
8
44
1.82
0.85
3.3
1.9
mmol/l
1.2
1.2
—
8
44
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
18
120
1.50
0.85
1.3
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
16
104
1.54
0.84
1.1
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
71
588
1.21
0.83
3.1
2.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
57
1.76
0.83
1.4
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
19
129
1.48
0.83
1.6
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
44
345
1.28
0.83
1.1
1.1
iu/ml
196.7
104.9
—
9
77
(3014891) Appearance of Pleural fluid
6
32
1.88
0.81
1.3
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
71
591
1.21
0.80
3.1
2.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
122
1.48
0.80
1.4
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
58
1.73
0.79
1.4
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
33
1.82
0.79
2.7
2.2
umol/l
10.8
17.9
—
6
33
(4146454)
32
242
1.33
0.79
3.3
2.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
11
66
1.67
0.78
2.3
1.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
19
131
1.45
0.78
1.6
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
74
1.62
0.78
1.3
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
69
576
1.20
0.77
2.8
2.2
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
6
34
1.77
0.76
1.0
1.1
—
1.5
—
0
23
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
24
2.09
0.74
1.6
1.8
umol/l
45.0
48.4
—
5
24
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
24
176
1.37
0.72
4.2
4.9
u/ml
67.0
43.1
—
7
51
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
39
1.80
0.72
1.0
1.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
20
142
1.41
0.72
1.1
1.9
umol/l
4.3
6.7
1.02
11
88
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
109
0.55
0.72
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
17
117
1.46
0.71
1.5
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
114
1000
1.15
0.71
3.8
2.5
%
0.6
0.7
0.32
109
958
(3010726) Horse dander IgE Ab [Units/volume] in Serum
34
264
1.29
0.71
1.0
1.0
u/ml
2.2
2.1
0.01
12
61
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
23
168
1.37
0.71
1.4
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
40
1.75
0.71
1.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
58
1.55
0.69
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
118
1.44
0.69
2.7
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
38
475
0.80
0.68
1.2
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
61
1.64
0.68
1.1
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
180
0.67
0.67
1.2
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
127
1128
1.13
0.67
2.3
2.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
15
102
1.47
0.67
2.2
2.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
17
119
1.43
0.67
1.5
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
58
485
1.20
0.66
2.6
2.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
29
1.73
0.64
1.2
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
29
1.73
0.64
2.2
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
69
590
1.17
0.62
1.3
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
40
324
1.24
0.62
1.5
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
11
71
1.55
0.62
1.2
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
62
526
1.18
0.61
1.3
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(4211845)
14
96
1.46
0.61
3.1
3.4
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
21.8
—
0
6
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
15
105
1.43
0.60
1.1
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
51
427
1.20
0.59
1.8
2.1
u/l
13137.4
3109.6
0.53
14
170
(3001019) Free T4 and TSH panel - Serum or Plasma
83
948
0.87
0.59
1.8
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
16
114
1.41
0.58
1.1
1.2
nmol/l
161.1
137.3
0.57
16
114
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
53
1.51
0.58
4.4
3.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
149
1352
1.11
0.57
1.3
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
54
1.48
0.57
1.4
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
36
1.67
0.56
1.7
1.3
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
17
124
1.37
0.55
1.1
1.5
ug/l
2.2
2.7
0.33
12
103
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
116
1.38
0.54
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
38
1.58
0.54
4.3
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
20
151
1.33
0.54
1.3
1.1
—
4.0
—
0
8
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
61
1.48
0.53
1.2
2.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
33
268
1.23
0.52
1.7
1.6
%
65.3
62.2
0.18
15
170
(3047181) Lactate [Moles/volume] in Blood
78
686
1.14
0.52
7.6
6.9
mmol/l
1.2
1.3
0.55
71
595
(3004119) Hemoglobin [Mass/volume] in Venous blood
146
1333
1.10
0.52
4.6
3.1
g/l
138.4
129.1
3.18
139
1295
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
83
1.45
0.51
1.8
2.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
65
1.39
0.50
1.1
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
65
1.39
0.50
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
98
877
1.12
0.50
5.7
5.9
%
0.9
0.9
0.14
93
811
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
41
1.46
0.50
1.2
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
45
1.56
0.49
1.7
2.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
56
646
0.86
0.48
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
207
1928
1.08
0.48
2.5
2.4
ug/l
8.0
7.2
0.19
173
1714
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
16
119
1.35
0.48
6.0
6.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
236
2211
1.07
0.47
1.6
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
104
940
1.11
0.46
2.2
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
42
356
1.18
0.46
1.4
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
50
1.40
0.45
1.1
2.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
51
1.37
0.44
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
51
1.37
0.44
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
51
1.37
0.44
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
51
1.37
0.44
1.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
25
202
1.24
0.43
1.8
2.6
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
57
648
0.88
0.42
2.2
1.8
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.1
—
0
9
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
34
1.47
0.40
1.6
3.7
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
60
1.33
0.40
1.1
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
18
141
1.28
0.40
1.1
1.1
nmol/l
10.1
5.3
—
5
31
(3019174) dRVVT (LA screen)
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
634
6146
1.04
0.39
3.8
4.2
%
22.2
21.6
0.45
298
2965
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
31
260
1.19
0.39
2.2
1.3
—
—
—
0
0
(44813793)
16
124
1.29
0.38
1.1
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
31
261
1.19
0.38
2.2
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
288
2742
1.06
0.38
1.4
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
22
179
1.23
0.37
2.1
1.8
%
10.0
11.3
0.70
22
179
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
31
262
1.19
0.37
2.2
1.3
—
—
—
0
0
(44806420)
9
70
1.29
0.36
2.3
2.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
24
198
1.21
0.36
1.3
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
21
255
0.82
0.35
2.5
2.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
32
273
1.17
0.35
1.0
1.1
u/ml
0.1
2.0
2.04
14
113
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
82
1.34
0.34
1.6
1.8
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
15
118
1.27
0.33
2.6
1.9
ug/min
22.4
208.8
—
5
30
(3025468) Yersinia sp identified in Specimen by Organism specific culture
30
256
1.17
0.33
2.2
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
30
256
1.17
0.33
2.2
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
33
284
1.16
0.33
1.1
1.1
u/ml
3.2
6.0
0.75
18
141
(4198724)
10
74
1.35
0.32
1.4
1.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
12
92
1.31
0.31
1.4
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
30
258
1.16
0.31
2.2
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
41
463
0.88
0.30
3.2
3.7
mg/l
17.0
27.4
2.55
29
286
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
56
1.25
0.29
1.6
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
65
592
1.10
0.29
1.7
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
13
103
1.26
0.28
1.2
1.3
mmol/l
6.0
6.1
0.09
13
97
(3020650) Glucose [Presence] in Urine
8
63
1.27
0.27
1.6
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
41
459
0.89
0.27
1.4
1.6
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
8
64
1.25
0.27
1.8
1.5
%
16.9
24.8
—
8
59
(3036071) Salmonella sp Ab [Titer] in Serum
9
73
1.23
0.25
1.0
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
13
105
1.24
0.24
2.5
1.3
umol/l
12.8
26.6
4.11
13
100
(3014599) Egg white IgE Ab [Units/volume] in Serum
12
96
1.25
0.24
1.0
1.0
u/ml
35.9
0.3
—
5
24
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
21
180
1.17
0.23
1.6
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
50
456
1.10
0.23
2.2
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
14
115
1.22
0.23
2.4
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
22
190
1.16
0.23
1.5
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
134
1.20
0.23
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
79
1.27
0.22
1.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
5
41
1.22
0.22
1.0
1.1
—
1.7
—
0
27
(3000475) Leukocytes [#/volume] in Synovial fluid
57
526
1.09
0.21
1.6
1.6
e6/l
18223.5
15375.5
0.16
41
379
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(4038314)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
2.6
—
0
10
(3018001) Oat IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.3
—
0
5
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
5.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
5
43
1.16
0.21
7.0
3.3
—
39.1
—
0
14
(40768793) Breast Pathology biopsy report
49
450
1.09
0.21
1.4
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
42
460
0.91
0.21
1.5
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
6
50
1.20
0.19
1.8
2.7
—
91.8
—
0
10
(4133840)
6
52
1.15
0.19
1.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
13
109
1.19
0.18
15.4
11.3
mmol/l
0.6
0.6
0.49
13
103
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
109
1.19
0.18
1.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
31
280
1.11
0.18
1.9
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
58
1.21
0.18
1.1
1.3
ug/l
8.4
9.3
—
7
58
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
59
1.19
0.18
1.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
60
1.17
0.17
1.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
26
233
1.12
0.17
1.0
1.0
u/ml
2.6
2.8
0.04
14
88
(4034850)
65
690
0.94
0.16
20.5
9.8
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
20
225
0.89
0.16
2.9
2.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
92
1.20
0.16
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
34
312
1.09
0.15
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
66
623
1.06
0.15
1.8
1.9
—
—
—
0
0
(4094501)
63
597
1.06
0.14
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
32
296
1.08
0.13
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
32
296
1.08
0.13
1.2
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
9
110
0.82
0.13
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
82
788
1.04
0.11
1.9
1.9
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
23
211
1.09
0.11
1.0
1.1
u/ml
2.5
3.9
0.33
12
81
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
48
457
1.05
0.09
2.1
3.7
u/ml
236.4
881.0
0.57
42
431
(3006462) Nitrate [Presence] in Urine
10
87
1.15
0.09
2.3
3.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
28
262
1.07
0.09
2.6
2.3
mg/l
13.0
22.5
—
5
65
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
160
1635
0.98
0.09
1.4
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
56
1.07
0.08
18.2
7.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
20
216
0.93
0.08
1.5
1.5
—
—
—
0
0
(4015189)
5
63
0.79
0.08
3.4
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
67
1.04
0.08
3.4
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
67
1.04
0.08
3.4
2.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
104
1066
0.97
0.07
3.4
3.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
86
1.05
0.07
1.0
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
87
1.03
0.07
1.7
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
91
0.88
0.06
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
95
0.84
0.06
1.6
13.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
35
364
0.96
0.05
1.7
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
263
2653
0.99
0.04
5.1
4.5
%
30.6
32.2
1.66
192
1766
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
16
169
0.95
0.03
1.0
1.0
ng/l
726.4
713.7
—
10
103
(3008037) Lactate [Moles/volume] in Venous blood
46
471
0.98
0.03
3.1
3.2
mmol/l
1.5
1.6
0.19
41
456
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
102
1.08
0.03
1.1
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
16
168
0.95
0.02
1.0
1.0
ng/l
302.5
299.3
0.01
11
105
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
16
168
0.95
0.02
1.0
1.0
ng/l
43.5
44.8
0.04
11
101
(4281824)
20
208
0.96
0.02
1.3
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
15
157
0.96
0.01
1.0
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
15
157
0.96
0.01
1.9
1.5
—
71.9
—
0
15
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
15
156
0.96
0.00
1.4
1.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
20
205
0.98
0.00
1.2
1.4
e6/l
101985.3
103629.9
0.01
15
138
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
13
127
1.02
0.00
1.0
1.4
—
1.4
—
0
8
(3044242) Glucose [Moles/volume] in Arterial blood
12
123
0.98
0.00
1.2
2.3
—
—
—
0
0
(4024509)
20
197
1.02
0.00
1.7
1.6
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017400) Magnesium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
2.5
—
0
5
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
77
0.91
0.00
1.1
1.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
49
1.02
0.00
21.6
7.7
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
51
0.98
0.00
1.2
1.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
79
1.01
0.00
1.1
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
19
190
1.00
0.00
1.0
1.0
u/ml
1.2
0.3
—
5
48
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint D3_OTHERBLOOD and mortality.

Females

Parameter HR [95% CI] p-value
D3_OTHERBLOOD 1.985 [1.78, 2.22] < 0.001
Birth year 0.996 [0.99, 1.0] 0.293

During the follow-up period (1.1.1998 — 31.12.2019), 1658 out of 6103 females with D3_OTHERBLOOD died.

Males

Parameter HR [95% CI] p-value
D3_OTHERBLOOD 1.825 [1.62, 2.05] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 1754 out of 6045 males with D3_OTHERBLOOD died.

Mortality risk

Mortality risk for people of age

years, who have D3_OTHERBLOOD.

N-year risk Females Males
1 0.216% 0.396%
5 1.289% 2.196%
10 3.139% 5.364%
15 5.656% 9.533%
20 10.057% 16.307%

Relationships between endpoints

↥

Index endpoint: D3_OTHERBLOOD – Other diseases of blood and blood-forming organs

GWS hits: 6

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data